Clinical Trial Update: Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting [Phase 4]

View source ↗

Summary

Phase 4 real-world study of Rhopressa for reducing elevated intraocular pressure in glaucoma or ocular hypertension completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• RHOPRESSA (NETARSUDIL)

Snippet

Sponsor: Aerie Pharmaceuticals | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2020-09-29